Drug-induced Hypersensitivity Syndrome by EGFR-TKI in a Patient with Lung Cancer

An 83-years-old woman diagnosed with advanced Epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma was administered afatinib as a first-line treatment. On Day 17, the patient presented with grade 3 diarrhea and a blood test analysis showed an increased inflammatory response. Afatinib t...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyama, Baku, Morikawa, Kei, Sakaguchi, Tadashi, Tsunoda, Akihito, Kida, Hirotaka, Inoue, Takeo, Mineshita, Masamichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925278/
https://www.ncbi.nlm.nih.gov/pubmed/33518612
http://dx.doi.org/10.2169/internalmedicine.4237-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925278/
https://www.ncbi.nlm.nih.gov/pubmed/33518612
http://dx.doi.org/10.2169/internalmedicine.4237-19

Ejemplares similares